The use of JAK inhibitors in the treatment of progressive systemic sclerosis

J Eur Acad Dermatol Venereol. 2018 Aug;32(8):e328. doi: 10.1111/jdv.14876. Epub 2018 Mar 6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Humans
  • Janus Kinase Inhibitors / therapeutic use*
  • Male
  • Piperidines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Pyrroles / therapeutic use*
  • Scleroderma, Systemic / diagnosis
  • Scleroderma, Systemic / drug therapy*

Substances

  • Janus Kinase Inhibitors
  • Piperidines
  • Pyrimidines
  • Pyrroles
  • tofacitinib